Filing Details

Accession Number:
0001628280-23-020508
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-01 16:27:50
Reporting Period:
2023-05-31
Accepted Time:
2023-06-01 16:27:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386570 Chromadex Corp. CDXC Medicinal Chemicals & Botanical Products (2833) 262940963
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1417952 N Robert Fried 10900 Wilshire Blvd. Suite 600
Los Angeles CA 90024
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-31 7,000 $1.42 95,001 No 4 P Indirect By Fried-Travis Revocable Trust U/A Dated 06/02/1999
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Fried-Travis Revocable Trust U/A Dated 06/02/1999
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 972,314 Direct
Common Stock 250,000 Indirect By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020
Common Stock 250,000 Indirect By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020
Common Stock 12,746 Indirect See Footnote
Footnotes
  1. 6,745 shares of Common Stock held by Jeremy Fried and 6,001 shares of Common Stock held by Benjamin Fried, who are both sons of Robert Fried.